Peripheral oxyntomodulin reduces food intake and body weight gain in rats

Endocrinology

Volumn 145, Issue 6, 2004, Pages 2687-2695

  Dakin, Catherine L ^a,b   Small, Caroline J ^a   Batterham, Rachel L ^a   Neary, Nicola M ^a   Cohen, Mark A ^a   Patterson, Michael ^a   Ghatei, Mohammad A ^a   Bloom, Stephen R ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

^b ST GEORGE S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EXENDIN[9-39]; GHRELIN; GLUCAGON LIKE PEPTIDE 1 RECEPTOR; OXYNTOMODULIN; PROTEIN C FOS; RECEPTOR BLOCKING AGENT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARCUATE NUCLEUS; ARTICLE; BLOOD BRAIN BARRIER; CONTROLLED STUDY; DIET RESTRICTION; DOSE RESPONSE; DRUG DOSE REGIMEN; FOOD INTAKE; IMMUNOREACTIVITY; MALE; NERVE CONDUCTION; NONHUMAN; PRIORITY JOURNAL; RAT; REDUCTION; REFEEDING; STOMACH EMPTYING; WEIGHT GAIN;

ANIMALS; APPETITE DEPRESSANTS; ARCUATE NUCLEUS; DARKNESS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; EATING; FASTING; GASTRIC EMPTYING; GLUCAGON; GLUCAGON-LIKE PEPTIDE 1; GLUCAGON-LIKE PEPTIDES; HUMANS; IMMUNOHISTOCHEMISTRY; INJECTIONS; INJECTIONS, INTRAPERITONEAL; MALE; OXYNTOMODULIN; PEPTIDE FRAGMENTS; PEPTIDE HORMONES; PHOTOPERIOD; PROTEIN PRECURSORS; RATS; RATS, WISTAR; RECEPTORS, GLUCAGON; WEIGHT GAIN;

EID: 2542460293     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/en.2003-1338     Document Type: Article

References (45)

1. Merchenthaler I, Lane M, Shughrue P 1999 Distribution of prepro-glucagon and glucagon-like peptide-1 receptor messenger RNAs in the rat central nervous system. J Comp Neurol 403:261-280
2. Tang-Christensen M, Vrang N, Larsen PJ 2001 Glucagon-like peptide containing pathways in the regulation of feeding behaviour. Int J Obes Relat Metab Disord 25(Suppl 5):S42-S47
3. Bataille D, Tatemoto K, Gespach C, Jornvall H, Rosselin G, Mutt V 1982 Isolation of glucagon-37 (bioactive enteroglucagon/oxyntomodulin) from porcine jejuno-ileum. Characterization of the peptide. FEBS Lett 146:79-86
4. Bataille D, Coudray AM, Carlqvist M, Rosselin G, Mutt V 1982 Isolation of glucagon-37 (bioactive enteroglucagon/oxyntomodulin) from porcine jejuno-ileum. Isolation of the peptide. FEBS Lett 146:73-78
5. Dubrasquet M, Bataille D, Gespach C 1982 Oxyntomodulin (glucagon-37 or bioactive enteroglucagon): a potent inhibitor of pentagastrin-stimulated acid secretion in rats. Biosci Rep 2:391-395
6. Jarrousse C, Carles-Bonnet C, Niel H, Bataille D 1994 Activity of oxyntomodulin on gastric acid secretion induced by histamine or a meal in the rat. Peptides 15:1415-1420
7. Schjoldager B, Mortensen PE, Myhre J, Christiansen J, Holst JJ 1989 Oxyntomodulin from distal gut. Role in regulation of gastric and pancreatic functions. Dig Dis Sci 34:1411-1419
8. Blache P, Kervran A, Bataille D 1988 Oxyntomodulin and glicentin: brain-gut peptides in the rat. Endocrinology 123:2782-2787
9. Dakin CL, Gunn I, Small CJ, Edwards CM, Hay DL, Smith DM, Ghatei MA, Bloom SR 2001 Oxyntomodulin inhibits food intake in the rat. Endocrinology 142:4244-4250
10. Dakin CL, Small CJ, Park AJ, Seth A, Ghatei MA, Bloom SR 2002 Repeated ICV administration of oxyntomodulin causes a greater reduction in body weight gain than in pair-fed rats. Am J Physiol Endocrinol Metab 283:E1173-E1177
11. Turton MD, O'Shea D, Gunn I, Beak SA, Edwards CM, Meeran K, Choi SJ, Taylor GM, Heath MM, Lambert PD, Wilding JP, Smith DM, Ghatei MA, Herbert J, Bloom SR 1996. A role for glucagon-like peptide-1 in the central regulation of feeding. Nature 379:69-72
12. Tang-Christensen M, Larsen PJ, Goke R, Fink-Jensen A, Jessop DS, Moller M, Sheikh SP 1996 Central administration of GLP-1-(7-36) amide inhibits food and water intake in rats. Am J Physiol 271:R848-R856
13. Rodriquez DF, Navarro M, Alvarez E, Roncero I, Chowen JA, Maestre O, Gomez R, Munoz RM, Eng J, Blazquez E 2000 Peripheral versus central effects of glucagon-like peptide-1 receptor agonists on satiety and body weight loss in Zucker obese rats. Metabolism 49:709-717
14. Larsen PJ, Fledelius C, Knudsen LB, Tang-Christensen M 2001 Systemic administration of the long-acting GLP-1 derivative NN2211 induces lasting and reversible weight loss in both normal and obese rats. Diabetes 50:2530-2539
15. Flint A, Raben A, Ersboll AK, Holst JJ, Astrup A 2001 The effect of physiological levels of glucagon-like peptide-1 on appetite, gastric emptying, energy and substrate metabolism in obesity. Int J Obes Relat Metab Disord 25:781-792
16. Batterham RL, Cowley MA, Small CJ, Herzog H, Cohen MA, Dakin CL, Wren AM, Brynes AE, Low MJ, Ghatei MA, Cone RD, Bloom SR 2002 Gut hormone PYY(3-36) physiologically inhibits food intake. Nature 418:650-654
17. Cone RD, Cowley MA, Butler AA, Fan W, Marks DL, Low MJ 2001 The arcuate nucleus as a conduit for diverse signals relevant to energy homeostasis. Int J Obes Relat Metab Disord 25(Suppl 5):S63-S67
18. Merchenthaler I 1991 Neurons with access to the general circulation in the central nervous system of the rat: a retrograde tracing study with fluoro-gold. Neuroscience 44:655-662
19. Hewson AK, Dickson SL 2000 Systemic administration of ghrelin induces Fos and Egr-1 proteins in the hypothalamic arcuate nucleus of fasted and fed rats. J Neuroendocrinol 12:1047-1049
20. Wang L, Saint-Pierre DH, Tache Y 2002 Peripheral ghrelin selectively increases Fos expression in neuropeptide Y-synthesizing neurons in mouse hypothalamic arcuate nucleus. Neurosci Lett 325:47-51
21. Kim MS, Rossi M, Abusnana S, Sunter D, Morgan DG, Small CJ, Edwards CM, Heath MM, Stanley SA, Seal LJ, Bhatti JR, Smith DM, Ghatei MA, Bloom SR 2000 Hypothalamic localization of the feeding effect of agouti-related peptide and α-melanocyte-stimulating hormone. Diabetes 49:177-182
22. Barrachina MD, Martinez V, Wei JY, Tache Y 1997 Leptin-induced decrease in food intake is not associated with changes in gastric emptying in lean mice. Am J Physiol 272:R1007-R1011
23. Ghatei MA, Uttenthal LO, Christofides ND, Bryant MG, Bloom SR 1983 Molecular forms of human enteroglucagon in tissue and plasma: plasma responses to nutrient stimuli in health and in disorders of the upper gastrointestinal tract. J Clin Endocrinol Metab 57:488-495
24. English PJ, Ghatei MA, Malik IA, Bloom SR, Wilding JP 2002 Food fails to suppress ghrelin levels in obese humans. J Clin Endocrinol Metab 87:2984
25. Lambert PD, Phillips PJ, Wilding JP, Bloom SR, Herbert J 1995 c-fos Expression in the paraventricular nucleus of the hypothalamus after intracerebroventricular infusions of neuropeptide Y. Brain Res 670:59-65
26. Paxinos G, Watson C 1998 The rat brain in stereotactic coordinates. London: Academic Press
27. Stanley SA, Small CJ, Kim MS, Heath MM, Seal LJ, Russell SH, Ghatei MA, Bloom SR 1999 Agouti related peptide (Agrp) stimulates the hypothalamo pituitary gonadal axis in vivo and in vitro in male rats. Endocrinology 140:5459-5462
28. Kim MS, Small CJ, Stanley SA, Morgan DG, Seal LJ, Kong WM, Edwards CM, Abusnana S, Sunter D, Ghatei MA, Bloom SR 2000 The central melanocortin system affects the hypothalamo-pituitary thyroid axis and may mediate the effect of leptin. J Clin Invest 105:1005-1011
29. Dhillo WS, Small CJ, Stanley SA, Jethwa PH, Seal LJ, Murphy KG, Ghatei MA, Bloom SR 2002 Hypothalamic interactions between neuropeptide Y, agouti-related protein, cocaine- and amphetamine-regulated transcript and α-melanocyte-stimulating hormone in vitro in male rats. J Neuroendocrinol 14:725-730
30. Druce M, Bloom SR 2003 Central regulators of food intake. Curr Opin Clin Nutr Metab Care 6:361-367
31. Schjoldager BT, Baldissera FG, Mortensen PE, Holst JJ, Christiansen J 1988 Oxyntomodulin: a potential hormone from the distal gut. Pharmacokinetics and effects on gastric acid and insulin secretion in man. Eur J Clin Invest 18:499-503
32. Naslund E, Bogefors J, Skogar S, Gryback P, Jacobsson H, Holst JJ, Hellstrom PM 1999 GLP-1 slows solid gastric emptying and inhibits insulin, glucagon, and PYY release in humans. Am J Physiol 277:R910-R916
33. Depigny C, Lupo B, Kervran A, Bataille D 1984 [Demonstration of a specific receptor site for glucagon-37 (oxyntomodulin/bioactive enteroglucagon) in rat oxyntic glands]. C R Acad Sci III 299:677-680
34. Rodier G, Magous R, Mochizuki T, Le Nguyen D, Martinez J, Bali JP, Bataille D, Jarrousse C, Genevieve R 1999 Glicentin and oxyntomodulin modulate both the phosphoinositide and cyclic adenosine monophosphate signaling pathways in gastric myocytes. Endocrinology 140:22-28
35. Schepp W, Dehne K, Riedel T, Schmidtler J, Schaffer K, Classen M 1996 Oxyntomodulin: a cAMP-dependent stimulus of rat parietal cell function via the receptor for glucagon-like peptide-1 (7-36)NH2. Digestion 57:398-405
36. Gros L, Thorens B, Bataille D, Kervran A1993 Glucagon-like peptide-1-(7-36) amide, oxyntomodulin, and glucagon interact with a common receptor in a somatostatin-secreting cell line. Endocrinology 133:631-638
37. Serre V, Dolci W, Schaerer E, Scrocchi L, Drucker D, Efrat S, Thorens B 1998 Exendin (9-39) is an inverse agonist of the murine glucagon-like peptide-1 receptor: implications for basal intracellular cyclic adenosine 3′,5′-monophosphate levels and β-cell glucose competence. Endocrinology 139:4448-4454
38. Malendowicz LK, Neri G, Nussdorfer GG, Nowak KW, Zyterska A, Ziolkowska A 2003 Prolonged exendin-4 administration stimulates pituitary-adrenocortical axis of normal and streptozotocin-induced diabetic rats. Int J Mol Med 12:593-596
39. Malendowicz LK, Nowak KW 2002 Preproglucagon derived peptides and thyrotropin (TSH) secretion in the rat: robust and sustained lowering of blood TSH levels in exendin-4 injected animals. Int J Mol Med 10:327-331
40. Besterman HS, Cook GC, Sarson DL, Christofides ND, Bryant MG, Gregor M, Bloom SR 1979 Gut hormones in tropical malabsorption. Br Med J 2:1252-1255
41. Sarson DL, Scopinaro N, Bloom SR 1981 Gut hormone changes after jejunoileal (JIB) or biliopancreatic (BPB) bypass surgery for morbid obesity. Int J Obes 5:471-480
42. Holst JJ, Sorensen TI, Andersen AN, Stadil F, Andersen B, Lauritsen KB, Klein HC 1979 Plasma enteroglucagon after jejunoileal bypass with 3:1 or 1:3 jejunoileal ratio. Scand J Gastroenterol 14:205-207
43. Wren AM, Small CJ, Abbott CR, Dhillo WS, Seal LJ, Cohen MA, Batterham RL, Taheri S, Stanley SA, Ghatei MA, Bloom SR 2001 Ghrelin causes hyperphagia and obesity in rats. Diabetes 50:2540-2547
44. Cummings DE, Purnell JQ, Frayo RS, Schmidova K, Wisse BE, Weigle DS 2001 A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans. Diabetes 50:1714-1719
45. Cohen MA, Ellis SM, Le Roux CW, Batterham RL, Park A, Patterson M, Frost GS, Ghatei MA, Bloom SR 2003 Oxyntomodulin suppresses appetite and reduces food intake in humans. J Clin Endocrinol Metab 88:4696-4701